Advertisement

Prevalence of depression in Parkinson's disease: Effects of disease stage, motor subtype and gender

Published:August 01, 2011DOI:https://doi.org/10.1016/j.jns.2011.07.007

      Abstract

      Depression is one of the most common non-motor symptoms of Parkinson's disease (PD) with a large negative impact on the quality of life. Factors such as disease stage, subtype of PD and gender might play an important role in the prevalence of depression, but a large study investigating all these factors in a within-subject design is lacking. Therefore we studied a homogeneous group of 256 Dutch PD patients (60% men, mean age=65.12 (±9.6) years). In total, 36.3% of the subjects had a BDI-score indicative for a minor depression, while 12.9% had a major depression. Notably, only 8.6% of the minor depressed patients and 30.3% of the major depressed patients were taking antidepressants. A higher prevalence of depression was observed in the later stages of the disease. However, this finding was absent in a smaller subsample after correction for cognitive impairment. Our data did not show a difference in the prevalence of depression between the motor subtypes and showed a trend towards higher prevalence of depression in the tremor dominant group. There was no significant difference in the prevalence of depression between men and women. We will discuss the relevance of these results in relation to the findings of other studies.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Slaughter J.R.
        • Slaughter K.A.
        • Nichols D.
        • Holmes S.E.
        • Martens M.P.
        Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease.
        J Neuropsychiatry Clin Neurosci. 2001; 13: 187-196
        • Reijnders J.S.
        • Ehrt U.
        • Weber W.E.
        • Aarsland D.
        • Leentjens A.F.
        A systematic review of prevalence studies of depression in Parkinson's disease.
        Mov Disord. 2008; 23: 183-189
        • Kuopio A.M.
        • Marttila R.J.
        • Helenius H.
        • Toivonen M.
        • Rinne U.K.
        The quality of life in Parkinson's disease.
        Mov Disord. 2000; 15: 216-223
        • Schrag A.
        Quality of life and depression in Parkinson's disease.
        J Neurol Sci. 2006; 248: 151-157
        • Dowding C.H.
        • Shenton C.L.
        • Salek S.S.
        A review of the health-related quality of life and economic impact of Parkinson's disease.
        Drugs Aging. 2006; 23: 693-721
        • Ravina B.
        • Camicioli R.
        • Como P.G.
        • Marsh L.
        • Jankovic J.
        • Weintraub D.
        • et al.
        The impact of depressive symptoms in early Parkinson disease.
        Neurology. 2007; 69: 342-347
        • Weintraub D.
        • Moberg P.J.
        • Duda J.E.
        • Katz I.R.
        • Stern M.B.
        Recognition and treatment of depression in Parkinson's disease.
        J Geriatr Psychiatry Neurol. 2003; 16: 178-183
        • Celesia G.G.
        • Wanamaker W.M.
        Psychiatric disturbances in Parkinson's disease.
        Dis Nerv Syst. 1972; 33: 577-583
        • Schrag A.
        • Jahanshahi M.
        • Quinn N.
        What contributes to quality of life in patients with Parkinson's disease?.
        J Neurol Neurosurg Psychiatry. 2000; 69: 308-312
        • Starkstein S.E.
        • Preziosi T.J.
        • Bolduc P.L.
        • Robinson R.G.
        Depression in Parkinson's disease.
        J Nerv Ment Dis. 1990; 178: 27-31
        • Braak H.
        • Ghebremedhin E.
        • Rub U.
        • Bratzke H.
        • Del T.K.
        Stages in the development of Parkinson's disease-related pathology.
        Cell Tissue Res. 2004; 318: 121-134
        • Leentjens A.F.
        • Van den A.M.
        • Metsemakers J.F.
        • Lousberg R.
        • Verhey F.R.
        Higher incidence of depression preceding the onset of Parkinson's disease: a register study.
        Mov Disord. 2003; 18: 414-418
        • Schuurman A.G.
        • Van den A.M.
        • Ensinck K.T.
        • Metsemakers J.F.
        • Knottnerus J.A.
        • Leentjens A.F.
        • et al.
        Increased risk of Parkinson's disease after depression: a retrospective cohort study.
        Neurology. 2002; 58: 1501-1504
        • Althaus A.
        • Becker O.A.
        • Spottke A.
        • Dengler R.
        • Schneider F.
        • Kloss M.
        • et al.
        Frequency and treatment of depressive symptoms in a Parkinson's disease registry.
        Parkinsonism Relat Disord. 2008; 14: 626-632
        • Riedel O.
        • Klotsche J.
        • Spottke A.
        • Deuschl G.
        • Forstl H.
        • Henn F.
        • et al.
        Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease.
        J Neurol. 2010; 257: 1073-1082
        • Rojo A.
        • Aguilar M.
        • Garolera M.T.
        • Cubo E.
        • Navas I.
        • Quintana S.
        Depression in Parkinson's disease: clinical correlates and outcome.
        Parkinsonism Relat Disord. 2003; 10: 23-28
        • Wichowicz H.M.
        • Slawek J.
        • Derejko M.
        • Cubala W.J.
        Factors associated with depression in Parkinson's disease: a cross-sectional study in a Polish population.
        Eur Psychiatry. 2006; 21: 516-520
        • Foltynie T.
        • Brayne C.
        • Barker R.A.
        The heterogeneity of idiopathic Parkinson's disease.
        J Neurol. 2002; 249: 138-145
        • Jankovic J.
        • McDermott M.
        • Carter J.
        • Gauthier S.
        • Goetz C.
        • Golbe L.
        • et al.
        Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group.
        Neurology. 1990; 40: 1529-1534
        • Zetusky W.J.
        • Jankovic J.
        • Pirozzolo F.J.
        The heterogeneity of Parkinson's disease: clinical and prognostic implications.
        Neurology. 1985; 35: 522-526
        • Dissanayaka N.N.
        • Sellbach A.
        • Silburn P.A.
        • O'Sullivan J.D.
        • Marsh R.
        • Mellick G.D.
        Factors associated with depression in Parkinson's disease.
        J Affect Disord. 2011; 132: 82-88
        • Papapetropoulos S.
        • Ellul J.
        • Argyriou A.A.
        • Chroni E.
        • Lekka N.P.
        The effect of depression on motor function and disease severity of Parkinson's disease.
        Clin Neurol Neurosurg. 2006; 108: 465-469
        • Schrag A.
        • Jahanshahi M.
        • Quinn N.P.
        What contributes to depression in Parkinson's disease?.
        Psychol Med. 2001; 31: 65-73
        • Starkstein S.E.
        • Petracca G.
        • Chemerinski E.
        • Teson A.
        • Sabe L.
        • Merello M.
        • et al.
        Depression in classic versus akinetic-rigid Parkinson's disease.
        Mov Disord. 1998; 13: 29-33
        • Paulus W.
        • Jellinger K.
        The neuropathologic basis of different clinical subgroups of Parkinson's disease.
        J Neuropathol Exp Neurol. 1991; 50: 743-755
        • Weissman M.M.
        • Bland R.
        • Joyce P.R.
        • Newman S.
        • Wells J.E.
        • Wittchen H.U.
        Sex differences in rates of depression: cross-national perspectives.
        J Affect Disord. 1993; 29: 77-84
        • Cubo E.
        • Bernard B.
        • Leurgans S.
        • Raman R.
        Cognitive and motor function in patients with Parkinson's disease with and without depression.
        Clin Neuropharmacol. 2000; 23: 331-334
        • Twelves D.
        • Perkins K.S.
        • Counsell C.
        Systematic review of incidence studies of Parkinson's disease.
        Mov Disord. 2003; 18: 19-31
        • Beck A.T.
        • Ward C.H.
        • Mendelson M.
        • Mock J.
        • Erbaugh J.
        An inventory for measuring depression.
        Arch Gen Psychiatry. 1961; 4: 561-571
        • Beck A.T.
        • Steer R.A.
        Internal consistencies of the original and revised Beck Depression Inventory.
        J Clin Psychol. 1984; 40: 1365-1367
        • Beck A.T.
        • Steer R.A.
        • Garbin M.G.
        Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation.
        Clin Psychol Rev. 1988; 8: 77-100
        • Costa A.
        • Peppe A.
        • Carlesimo G.A.
        • Pasqualetti P.
        • Caltagirone C.
        Major and minor depression in Parkinson's disease: a neuropsychological investigation.
        Eur J Neurol. 2006; 13: 972-980
        • Schrag A.
        • Barone P.
        • Brown R.G.
        • Leentjens A.F.
        • McDonald W.M.
        • Starkstein S.
        • et al.
        Depression rating scales in Parkinson's disease: critique and recommendations.
        Mov Disord. 2007; 22: 1077-1092
        • Esselink R.A.
        • de Bie R.M.
        • de Haan R.J.
        • Lenders M.W.
        • Nijssen P.C.
        • Staal M.J.
        • et al.
        Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial.
        Neurology. 2004; 62: 201-207
        • Hoehn M.M.
        • Yahr M.D.
        Parkinsonism: onset, progression and mortality.
        Neurology. 1967; 17: 427-442
        • Kuzis G.
        • Sabe L.
        • Tiberti C.
        • Leiguarda R.
        • Starkstein S.E.
        Cognitive functions in major depression and Parkinson disease.
        Arch Neurol. 1997; 54: 982-986
        • Tandberg E.
        • Larsen J.P.
        • Aarsland D.
        • Laake K.
        • Cummings J.L.
        Risk factors for depression in Parkinson disease.
        Arch Neurol. 1997; 54: 625-630
        • Folstein M.F.
        • Folstein S.E.
        • McHugh P.R.
        “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician.
        J Psychiatr Res. 1975; 12: 189-198
        • Fahn S.
        • Elton R.L.
        • Members of the UDC
        Unified Parkinson's Disease Rating Scale.
        in: Fahn S. Marsden C.D. Calne D.B. Goldstein M. Recent developments in Parkinson's disease rating scale II. MacMillian Healthcare Information, Florham Park, NJ1987: 153-163
        • Rijpkema M.
        • Everaerd D.
        • van der Pol C.
        • Franke B.
        • Tendolkar I.
        • Fernandez G.
        Normal sexual dimorphism in the human basal ganglia.
        Hum Brain Mapp. 2011; (Epub ahead of print)
        • Rodriguez-Oroz M.C.
        • Jahanshahi M.
        • Krack P.
        • Litvan I.
        • Macias R.
        • Bezard E.
        • et al.
        Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms.
        Lancet Neurol. 2009; 8: 1128-1139
        • Phillips M.L.
        • Drevets W.C.
        • Rauch S.L.
        • Lane R.
        Neurobiology of emotion perception II: implications for major psychiatric disorders.
        Biol Psychiatry. 2003; 54: 515-528
        • Visser M.
        • Leentjens A.F.
        • Marinus J.
        • Stiggelbout A.M.
        • van Hilten J.J.
        Reliability and validity of the Beck depression inventory in patients with Parkinson's disease.
        Mov Disord. 2006; 21: 668-672
        • Leentjens A.F.
        • Verhey F.R.
        • Luijckx G.J.
        • Troost J.
        The validity of the Beck Depression Inventory as a screening and diagnostic instrument for depression in patients with Parkinson's disease.
        Mov Disord. 2000; 15: 1221-1224